3 ms·
I like reading Derek Lowe because he's one of the few prominent scientist authors who actually just comes out and calls the modern narrative about drug discover
by dekhn 5y ago
I like reading Derek Lowe because he's one of the few prominent scientist authors who actually just comes out and calls the modern narrative about drug discovery a fiction.
SV has this weird addiction to rapid success and biotech drug discovery is sort of the opposite of that. So there are a lot of cases where a data scientist thinks they applied some magic tech and solved a hard bottleneck that will suddenly transform drug discovery into an efficient scientific enterprise.
That's not going to happen. There is no magic loss function that solves the hard problem and even if you had a computer that could compute NP-complete problems quickly, it wouldn't change the process at all.
Instead, the one step that would be the most effective is to make a model that could predict if a late stage molecule could get through FDA approval using only the data that is submitted to the FDA (lots of boring paperwork about trials). With prediction accuracy (both false positive and negative below 1%) you could easily save an enormous amount of time and money.